Phase II Trial of Weekly Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: KTOSG Trial 1301

被引：0
|
作者：
Sakata, Shinya [1 ]
Saeki, Sho [1 ]
Okamoto, Isamu [2 ]
Otsubo, Kohei [2 ]
Komiya, Kazutoshi [3 ]
Morinaga, Ryotaro [4 ]
Yoneshima, Yasuto [2 ]
Koga, Yuichiro [2 ]
Enokizu, Aimi [2 ]
Kishi, Hiroto [5 ]
Hirosako, Susumu [1 ]
Yamaguchi, Emi [1 ]
Aragane, Naoko [3 ]
Fujii, Shinji [6 ]
Harada, Taishi [2 ]
Iwama, Eiji [2 ]
Nakanishi, Yoichi [2 ]
Kohrogi, Hirotsugu [1 ]
机构：
[1] Kumamoto Univ Hosp, Dept Resp Med, Kumamoto, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan
[3] Saga Univ, Saga, Japan
[4] Oita Prefectural Hosp, Dept Resp Med & Oncol, Oita, Japan
[5] Kumamoto City Hosp, Dept Resp Med, Kumamoto, Japan
[6] Kumamoto Reg Med Ctr, Div Resp Dis, Kumamoto, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
non-small cell lung cancer; objective response rate; nab-paclitaxel; phase II trial;
D O I：
10.1016/j.jtho.2016.11.1266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03a-056
引用
收藏
页码：S923 / S923
页数：1
相关论文
共 50 条
  • [41] A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
    Tachihara, Motoko
    Kiriu, Tatsunori
    Hata, Akito
    Hatakeyama, Yukihisa
    Nakata, Kyosuke
    Nagano, Tatsuya
    Yamamoto, Masatsugu
    Kobayashi, Kazuyuki
    Ohnishi, Hisashi
    Katakami, Nobuyuki
    Nishimura, Yoshihiro
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7135 - 7140
  • [42] A Phase II Study of Nab-Paclitaxel (Nab-P) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations
    Baik, Christina
    Goulart, Bernardo
    Nguyen, Katherine
    Lee, Sylvia
    Eaton, Keith
    Chow, Laura
    Rodriguez, Cristina
    Santana-Davila, Rafael
    Wood, Rebecca
    Martins, Renato
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1227 - S1227
  • [43] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [44] Phase II trial of biweekly carboplatin and nab-paclitaxel with concurrent radiotherapy for patients with locally advanced unresectable stage III non-small cell lung cancer.
    Tanaka, Hisashi
    Okumura, Fumihiko
    Tabe, Chiori
    Ishioka, Yoshiko
    Itoga, Masamichi
    Taima, Kageaki
    Hasegawa, Yukihiro
    Yokouchi, Junichi
    Takanashi, Shingo
    Aoki, Masahiko
    Tasaka, Sadatomo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] A randomized Phase III trial of weekly or 3-weekly doses of nab-paclitaxel versus weekly doses of Cremophor-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE Trial)
    Koizumi, Wasaburo
    Morita, Satoshi
    Sakata, Yuh
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (03) : 303 - 306
  • [46] nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)
    Morgensztern, Daniel
    Dols, Manuel Cobo
    Aix, Santiago Ponce
    Postmus, Pieter E.
    Bennouna, Jaafar
    Fischer, Jurgen R.
    Juan-Vidal, Oscar
    Stewart, David J.
    Ardizzoni, Andrea
    Bhore, Rafia
    Wolfsteiner, Marianne
    Reck, Martin
    Talbot, Denis
    Govindan, Ramaswamy
    Ong, Teng Jin
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [47] Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175
    Gentzler, Ryan D.
    Mohindra, Nisha A.
    Jalal, Shadia, I
    Reckamp, Karen L.
    Hall, Richard D.
    Hanna, Nasser H.
    Chae, Young Kwang
    Koczywas, Marianna
    Helenowski, Irene B.
    Patel, Jyoti D.
    ONCOLOGIST, 2024, 29 (01): : 47 - 56
  • [48] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
    Nakadate, Megumi
    Yamazaki, Koichi
    Konishi, Jun
    Kinoshita, Ichiro
    Sukoh, Noriaki
    Harada, Masao
    Akie, Kenji
    Ogura, Shigeaki
    Ishida, Takashi
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
  • [49] Phase II Study of Carboplatin plus Weekly Nab-Paclitaxel in Elderly Patients with NSCLC: North Japan Lung Cancer Study Group Trial 1301
    Ishimoto, Osamu
    Usui, Kazuhiro
    Maemondo, Makoto
    Miyauchi, Eisaku
    Saito, Heisuke
    Fujita, Yuka
    Kato, Terufumi
    Suzuki, Toshiro
    Nakagawa, Taku
    Harada, Toshiyuki
    Miura, Hiroyuki
    Watanabe, Hiroshi
    Inoue, Akira
    Ichinose, Masakazu
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S657 - S658
  • [50] Phase I/II trial of weekly docetaxel and carboplatin in previously untreated patients with advanced non-small cell lung cancer.
    Walsh, W
    Gordon, J
    Merolli, R
    Seidler, C
    Kasturi, V
    Finn, T
    Liu, Q
    Strauss, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 691S - 691S
12345